Zydus Lifesciences Gestion
Gestion contrôle des critères 3/4
Le PDG Zydus Lifesciences est Sharvil Patel, nommé en Apr2017, a un mandat de 7.58 ans. La rémunération annuelle totale est ₹ 300.00M, composée du salaire de 60% et des bonus 40%, y compris les actions et options de la société. détient directement 0.001% des actions de la société, d'une valeur de ₹ 14.04M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 6.5 ans et 7.3 ans.
Informations clés
Sharvil Patel
Directeur général
₹300.0m
Rémunération totale
| Pourcentage du salaire du PDG | 60.0% |
| Durée du mandat du directeur général | 7.6yrs |
| Propriété du PDG | 0.001% |
| Durée moyenne d'occupation des postes de direction | 6.5yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 7.3yrs |
Mises à jour récentes de la gestion
Recent updates
Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Just Reported Earnings, And Analysts Cut Their Target Price
Nov 15
Here's Why We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Is Well Worth Watching
Sep 14Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Business And Shares Still Trailing The Market
Aug 30Zydus Lifesciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Aug 14Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment
Aug 03Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
Jul 19Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 05Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
Jun 20Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Jun 10Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
May 25Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?
Mar 18Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%
Feb 28Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report
Feb 12Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Dec 27Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors
Dec 06With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case
Aug 23Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00
Jul 17We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt
Jul 15Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's
Jun 24Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00
Jun 10Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00
May 21Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly
Feb 15Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹43b |
| Jun 30 2024 | n/a | n/a | ₹42b |
| Mar 31 2024 | ₹300m | ₹180m | ₹38b |
| Dec 31 2023 | n/a | n/a | ₹30b |
| Sep 30 2023 | n/a | n/a | ₹28b |
| Jun 30 2023 | n/a | n/a | ₹25b |
| Mar 31 2023 | ₹263m | ₹180m | ₹20b |
| Dec 31 2022 | n/a | n/a | ₹21b |
| Sep 30 2022 | n/a | n/a | ₹20b |
| Jun 30 2022 | n/a | n/a | ₹22b |
| Mar 31 2022 | ₹200m | ₹180m | ₹22b |
| Dec 31 2021 | n/a | n/a | ₹23b |
| Sep 30 2021 | n/a | n/a | ₹23b |
| Jun 30 2021 | n/a | n/a | ₹23b |
| Mar 31 2021 | ₹263m | ₹180m | ₹22b |
| Dec 31 2020 | n/a | n/a | ₹18b |
| Sep 30 2020 | n/a | n/a | ₹17b |
| Jun 30 2020 | n/a | n/a | ₹13b |
| Mar 31 2020 | ₹250m | ₹247m | ₹12b |
| Dec 31 2019 | n/a | n/a | ₹12b |
| Sep 30 2019 | n/a | n/a | ₹14b |
| Jun 30 2019 | n/a | n/a | ₹17b |
| Mar 31 2019 | ₹250m | ₹248m | ₹18b |
| Dec 31 2018 | n/a | n/a | ₹20b |
| Sep 30 2018 | n/a | n/a | ₹20b |
| Jun 30 2018 | n/a | n/a | ₹21b |
| Mar 31 2018 | ₹250m | ₹248m | ₹18b |
Rémunération vs marché: La rémunération totale de Sharvil ($USD 3.55M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Indian ($USD 1.10M ).
Rémunération et revenus: La rémunération de Sharvil a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Sharvil Patel (45 yo)
7.6yrs
Titularisation
₹300,000,000
Compensation
Dr. Sharvil Pankajbhai Patel has been Managing Director of Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) since April 1, 2017 and previously served as its Joint Managing Director...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| MD & Executive Director | 7.6yrs | ₹300.00m | 0.0015% ₹ 14.0m | |
| COO & Executive Director | 7.3yrs | ₹140.00m | 0.035% ₹ 330.4m | |
| President & CEO of America | 1.1yrs | pas de données | pas de données | |
| Chief Financial Officer | no data | ₹54.31m | pas de données | |
| Head of Investor Relations | no data | pas de données | pas de données | |
| Company Secretary & Compliance Officer | 5.8yrs | ₹2.09m | pas de données |
6.5yrs
Durée moyenne de l'emploi
Gestion expérimentée: L'équipe dirigeante de ZYDUSLIFE est chevronnée et expérimentée (6.5 années d'ancienneté moyenne).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| MD & Executive Director | 27.3yrs | ₹300.00m | 0.0015% ₹ 14.0m | |
| COO & Executive Director | 7.3yrs | ₹140.00m | 0.035% ₹ 330.4m | |
| Non-Executive Chairman | 29.5yrs | ₹1.20m | 74.98% ₹ 716.0b | |
| Independent Director | 8.5yrs | ₹4.00m | pas de données | |
| Non-Executive Non-Independent Director | 27.3yrs | ₹4.00m | 0.0012% ₹ 11.1m | |
| Independent Non-Executive Director | 5.9yrs | ₹4.10m | pas de données | |
| Independent Director | 2yrs | ₹3.50m | pas de données | |
| Independent Director | 2yrs | ₹3.50m | pas de données | |
| Independent Director | less than a year | pas de données | 0.00044% ₹ 4.2m |
7.3yrs
Durée moyenne de l'emploi
56yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de ZYDUSLIFE sont considérés comme expérimentés (ancienneté moyenne 7.3 ans).